• 33852 Citations
  • 78 h-Index
1982 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Yung Jue Bang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Safety and efficacy of durvalumab and tremelimumab alone or in combination in patients with advanced gastric and gastroesophageal junction adenocarcinoma

Kelly, R. J., Lee, J., Bang, Y. J., Almhanna, K., Blum-Murphy, M., Catenacci, D. V. T., Chung, H. C., Wainberg, Z. A., Gibson, M. K., Lee, K. W., Bendell, J. C., Denlinger, C. S., Chee, C. E., Omori, T., Leidner, R., Lenz, H. J., Chao, Y., Rebelatto, M. C., Brohawn, P. Z., He, P. & 4 others, McDevitt, J., Sheth, S., Englert, J. M. & Ku, G. Y., 15 Feb 2020, In : Clinical Cancer Research. 26, 4, p. 846-854 9 p.

Research output: Contribution to journalArticle

Open Access
  • Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study

    Bang, Y. J., Li, C. P., Lee, K. H., Chiu, C. F., Park, J. O., Shan, Y. S., Kim, J. S., Chen, J. S., Shim, H. J., Rau, K. M., Choi, H. J., Oh, D. Y., Belanger, B. & Chen, L. T., 1 Feb 2020, In : Cancer Science. 111, 2, p. 513-527 15 p.

    Research output: Contribution to journalArticle

    Open Access
  • Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts

    Bang, Y. J., Su, W. C., Schuler, M., Nam, D. H., Lim, W. T., Bauer, T. M., Azaro, A., Poon, R. T. P., Hong, D., Lin, C. C., Akimov, M., Ghebremariam, S., Zhao, S., Giovannini, M. & Ma, B., 1 Feb 2020, In : Cancer Science. 111, 2, p. 536-547 12 p.

    Research output: Contribution to journalArticle

    Open Access
  • Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study

    Kato, H., de Souza, P., Kim, S. W., Lickliter, J. D., Naito, Y., Park, K., Kumar, S., Mugundu, G. M. & Bang, Y. J., 1 Feb 2020, In : Targeted Oncology. 15, 1, p. 75-84 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • TDP1 and TOP1 modulation in Olaparib-resistant cancer determines the efficacy of subsequent chemotherapy

    Kim, J. W., Min, A., Im, S. A., Jang, H., Kim, Y. J., Kim, H. J., Lee, K. H., Kim, T. Y., Lee, K. W., Oh, D. Y., Kim, J. H. & Bang, Y. J., Feb 2020, In : Cancers. 12, 2, 334.

    Research output: Contribution to journalArticle

    Open Access